Compile Data Set for Download or QSAR
maximum 50k data
Found 700 with Last Name = 'beato' and Initial = 'c'
TargetREST corepressor 1(Homo sapiens (Human))
University Of Parma

Curated by ChEMBL
LigandPNGBDBM50498143(CHEMBL3407602)
Affinity DataIC50:  31nMAssay Description:Inhibition of human recombinant KDM1A/CoREST complex expressed in Escherichia coli using mono-methylated H3-K4 peptide containing 21 amino acids as s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetREST corepressor 1(Homo sapiens (Human))
University Of Parma

Curated by ChEMBL
LigandPNGBDBM50498128(CHEMBL3410944)
Affinity DataIC50:  35nMAssay Description:Inhibition of human recombinant KDM1A/CoREST complex expressed in Escherichia coli using mono-methylated H3-K4 peptide containing 21 amino acids as s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetREST corepressor 1(Homo sapiens (Human))
University Of Parma

Curated by ChEMBL
LigandPNGBDBM50498142(CHEMBL3407601)
Affinity DataIC50:  38nMAssay Description:Inhibition of human recombinant KDM1A/CoREST complex expressed in Escherichia coli using mono-methylated H3-K4 peptide containing 21 amino acids as s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetREST corepressor 1(Homo sapiens (Human))
University Of Parma

Curated by ChEMBL
LigandPNGBDBM50498137(CHEMBL3410941)
Affinity DataIC50:  47nMAssay Description:Inhibition of human recombinant KDM1A/CoREST complex expressed in Escherichia coli using mono-methylated H3-K4 peptide containing 21 amino acids as s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetREST corepressor 1(Homo sapiens (Human))
University Of Parma

Curated by ChEMBL
LigandPNGBDBM50498150(CHEMBL3407599)
Affinity DataIC50:  79nMAssay Description:Inhibition of human recombinant KDM1A/CoREST complex expressed in Escherichia coli using mono-methylated H3-K4 peptide containing 21 amino acids as s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetREST corepressor 1(Homo sapiens (Human))
University Of Parma

Curated by ChEMBL
LigandPNGBDBM50498135(CHEMBL3407603)
Affinity DataIC50:  94nMAssay Description:Inhibition of human recombinant KDM1A/CoREST complex expressed in Escherichia coli using mono-methylated H3-K4 peptide containing 21 amino acids as s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetREST corepressor 1(Homo sapiens (Human))
University Of Parma

Curated by ChEMBL
LigandPNGBDBM50498134(CHEMBL3407605)
Affinity DataIC50:  96nMAssay Description:Inhibition of human recombinant KDM1A/CoREST complex expressed in Escherichia coli using mono-methylated H3-K4 peptide containing 21 amino acids as s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568973(3-cyano-2,6-difluoro-N-(3- (furan-3-yl)-1H-indazol...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568973(3-cyano-2,6-difluoro-N-(3- (furan-3-yl)-1H-indazol...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568974(N-(3-(5-chloropyridin-3-yl)- 1H-indazol-5-yl)-5-cy...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568975(5-cyano-2-fluoro-N-(3- (furan-3-yl)-1H-indazol-5- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568975(5-cyano-2-fluoro-N-(3- (furan-3-yl)-1H-indazol-5- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568976(5-cyano-N-(3-(1,5-dimethyl- 1H-pyrazol-4-yl)-1H-in...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568977(4-cyano-N-(3-(furan-3-yl)- 1H-indazol-5-yl)-1-meth...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568977(4-cyano-N-(3-(furan-3-yl)- 1H-indazol-5-yl)-1-meth...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568979(N-(3-(1H-imidazol-1-yl)-1H- indazol-5-yl)-5-cyano-...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568980(6-cyano-N-(3-(furan-3-yl)- 1H-indazol-5-yl)picolin...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568980(6-cyano-N-(3-(furan-3-yl)- 1H-indazol-5-yl)picolin...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568981(3-cyano-2-fluoro-N-(3- (furan-3-yl)-1H-indazol-5- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568981(3-cyano-2-fluoro-N-(3- (furan-3-yl)-1H-indazol-5- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568982(5-cyano-3-methyl-N-(3-(2- methyloxazol-5-yl)-1H- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568982(5-cyano-3-methyl-N-(3-(2- methyloxazol-5-yl)-1H- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568983(5-cyano-N-(3-(4- cyanothiophen-2-yl)-1H- indazol-...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568983(5-cyano-N-(3-(4- cyanothiophen-2-yl)-1H- indazol-...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568984(5-cyano-N-(3-(5- cyanothiophen-2-yl)-1H- indazol-...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568985(4-cyano-N-(3-(furan-3-yl)- 1H-indazol-5-yl)pyrimid...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568985(4-cyano-N-(3-(furan-3-yl)- 1H-indazol-5-yl)pyrimid...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568854(US11427558, Example 1)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568854(US11427558, Example 1)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568855(US11427558, Example 2)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568855(US11427558, Example 2)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568856(US11427558, Example 3)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568856(US11427558, Example 3)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568857(US11427558, Example 4)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568857(US11427558, Example 4)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568858(US11427558, Example 5)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568858(US11427558, Example 5)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568859(US11427558, Example 6)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568859(US11427558, Example 6)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568860(US11427558, Example 7)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568986(5-cyano-N-(3-(furan-3-yl)- 1H-indazol-5-yl)-4-meth...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568987(3-cyano-6-fluoro-N-(3- (furan-3-yl)-1H-indazol-5- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568987(3-cyano-6-fluoro-N-(3- (furan-3-yl)-1H-indazol-5- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568990(5-cyano-N-(3-(furan-3-yl)- 1H-indazol-5-yl)-3-meth...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568990(5-cyano-N-(3-(furan-3-yl)- 1H-indazol-5-yl)-3-meth...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568991(3-bromo-5-cyano-N-(3- (furan-3-yl)-1H-indazol-5- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568991(3-bromo-5-cyano-N-(3- (furan-3-yl)-1H-indazol-5- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568992(N-(3-(5-chlorothiophen-2- yl)-1H-indazol-5-yl)-5- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568993(5-cyano-3-methyl-N-(3-(2- methylthiazol-5-yl)-1H- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Escape Bio

US Patent
LigandPNGBDBM568993(5-cyano-3-methyl-N-(3-(2- methylthiazol-5-yl)-1H- ...)
Affinity DataIC50: <100nMAssay Description:The assay was carried out under the following protocol conditions: 1 mM compound in DMSO was serially diluted 1:3, 11 points in DMSO with a Biomek FX...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 700 total ) | Next | Last >>
Jump to: